Uncategorised - European Medical Journal

Continue
EMJ
4 Mins
24th April 2014

Aspirin Can Reduce Colorectal Cancer Risks for Those with Specific Gene

The humble aspirin may have just added another beneficial effect beyond its ability to ameliorate headaches and reduce the risk of heart attacks…
EMJ
2 Mins
15th April 2014

Enzyme Revealed as Promising Target to Treat Asthma and Cancer

In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells…
EMJ
2 Mins
11th April 2014

Review of Testosterone-Containing Medicines Started

The European Medicines Agency has started a review of testosterone-containing medicines, mainly used in men who do not produce enough testosterone…
EMJ
3 Mins
10th April 2014

International Coeliac Day 16 May 2014

As part of this year’s International Coeliac Day, AOECS is raising awareness for an improvement in diagnosis rates of coeliac disease.
EMJ
2 Mins
8th April 2014

Caffeine against Alzheimer’s Disease

As part of a German-French research project, a team led by Dr. Christa E. Müller from the University of Bonn and Dr. David Blum from the…
EMJ
2 Mins
1st April 2014

Adverse Events

A year after I graduated, I was working in an emergency department when one of my colleagues killed someone.
EMJ
4 Mins
30th March 2014

Analysis of EUROMAX and HORIZONS-AMI Trials of the Medicines Company’s Angiomax(R) (Bivalirudin) Presented at ACC.14

Analysis of EUROMAX and HORIZONS-AMI Trials of the Medicines Company’s Angiomax(R) (Bivalirudin) Presented at ACC.14
EMJ
3 Mins
27th March 2014

Yogurt in Nutrition Initiative Welcomes the Expertise of the International Osteoporosis Foundation as It Highlights the Role of Dairy Products on Bone Health

The importance of dairy products, including yogurt, to bone health has been recognised again today with the announcement of a new collaboration between…
EMJ
2 Mins
27th March 2014

Norgine and Innovacell Dose First Patient in Phase IIb Clinical Trial of ICEF15, a Personalised Cell Therapy to Treat Faecal Incontinence

Norgine B.V. (“Norgine”) and Innovacell today announced that the first patient has been dosed in the Phase IIb STEFFI study, which has been designed to…
EMJ
1 Mins
14th March 2014

‘Early Access’ Scheme Unveiled for Innovative Medicines

People with advanced cancer and other serious illnesses like dementia could soon benefit from early access to innovative and promising treatments.